The "Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Packaging Offered, Scale of Operation, End Users and Key Geographical Regions" report has been added to ResearchAndMarkets.com's offering.

The Pharmaceutical Contract Manufacturing Market is valued at USD 99 billion in 2024 growing at a CAGR of 4.3% during the forecast period 2024-2035.

In the rapidly evolving pharmaceutical landscape, small molecule drugs continue to play a pivotal role in shaping innovation and development. Currently, small molecules account for 90% of all pharmaceutical drugs, even as biologics have gained more attention in recent years due to their ability to address a wide range of disorders.

The sector has also seen a resurgence in the approval of novel small molecule drugs, with over 50 candidates receiving approval from the US FDA in 2020 alone. This trend has significantly boosted the demand for services provided by pharmaceutical contract research organizations (CROs).

It is important to note that the manufacturing of these novel drug candidates necessitates specialized facilities, advanced equipment, and operational expertise. Consequently, pharmaceutical companies may face challenges in conducting development and manufacturing operations independently.

Additionally, the time and cost associated with establishing or acquiring manufacturing capabilities have driven both small and large pharmaceutical companies to increasingly outsource their manufacturing operations to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs). The pressing need for safer and more effective drugs has further heightened the demand for contract manufacturing services.

Influenced by the desire for improved efficiency, traceability, and cost-effectiveness, pharmaceutical contract manufacturing is undergoing significant technological advancements. Outsourcing manufacturing operations to CMOs and CDMOs involves implementing specialized solutions to optimize production workflows, ensure regulatory compliance, and uphold product quality standards.

Moreover, there is a growing focus on personalized medicine, which requires flexible manufacturing capabilities to cater to diverse patient needs. As pharmaceutical companies adapt to these evolving dynamics, the demand for advanced solutions tailored to the specific requirements of contract manufacturing services is anticipated to increase in the coming years.

Key Benefits of Buying this Report

• The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a pulse on the Pharmaceutical Contract Manufacturing Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

• AMRI Global
• Altasciences
• Cambrex
• Catalent
• DPT Laboratories
• Aenova
• Almac
• Corden Pharma
• Fresenius Kabi
• Glatt
• Hovione
• Recipharm
• Siegfried
• CMIC Group
• Nectar Lifesciences
• Syngene
• WuXi AppTec 

Key Topics Covered:

1. PREFACE

2. RESEARCH METHODOLOGY

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

3.1. Chapter Overview

3.2. Market Dynamics

4. EXECUTIVE SUMMARY

5. INTRODUCTION

5.1. Chapter Overview

5.2. Overview of Pharmaceutical Packaging

5.3. Advantages of Pharmaceutical Packaging

5.4. Types of Pharmaceutical Packaging

5.5. Need for Sustainable Pharmaceutical Packaging

5.6. Sustainable Pharmaceutical Packaging Solutions

5.7. Regulatory Framework

5.8. Advantages of Sustainable Packaging Materials

5.9. Limitations of Sustainable Packaging Materials

5.10. Future Perspectives

6. MARKET LANDSCAPE

6.1. Chapter Overview

6.2. Sustainable Packaging Providers: Overall Market Landscape

7. DETAILED COMPANY PROFILES

7.1. Chapter Overview

7.2. Drug Plastics

7.3. DS SMITH

7.4. MM Board & Paper

7.5. Mondi

7.6. PGP GLASS

7.7. Smurfit Kappa

7.8. Syntegon

7.9. Berry Global

7.10. Huhtamaki

7.11. SGD Pharma

8. SHORT COMPANY PROFILES

8.1. Chapter Overview

8.2. Amcor

8.3. Bormioli Pharma

8.4. EPL

8.5. Gerresheimer

8.6. Greiner Packaging

8.7. International Paper

8.8. PPC Flexible Packaging

8.9. Stoelzle Glass

8.10. Takemoto Packaging

8.11. Tekni-Plex

9. COMPANY COMPETITIVENESS ANALYSIS

9.1. Chapter Overview

9.2. Assumptions and Key Parameters

9.3. Methodology

9.4. Sustainable Packaging Providers: Company Competitiveness Analysis

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview

10.2. Partnership Models

10.3. Sustainable Packaging Providers: Partnerships and Collaborations

11. FUNDING AND INVESTMENTS

11.1. Chapter Overview

11.2. Funding Models

11.3. Sustainable Packaging Providers: Funding and Investments

12. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

13. DEMAND ANALYSIS

13.1. Chapter Overview

13.2. Key Assumptions and Methodology

13.3. Global Demand for Sustainable Packaging in Healthcare Industry, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)

14. GLOBAL SUSTAINABLE PACKAGING MARKET

14.1. Chapter Overview

14.2. Key Assumptions and Methodology

14.3. Global Sustainable Packaging Market, Historical Trends (2019-2023) and Forecasted Estimates (2024-2035)

15. SUSTAINABLE PACKAGING MARKET, BY TYPE OF ECO-FRIENDLY PACKAGING

15.1. Chapter Overview

15.2. Key Assumptions and Methodology

15.3. Sustainable Packaging Market: Distribution by Eco-friendly Packaging, 2024, 2028 and 2035

16. SUSTAINABLE PACKAGING MARKET, BY TYPE OF PACKAGING

16.1. Chapter Overview

16.2. Key Assumptions and Methodology

16.3. Sustainable Packaging Market: Distribution by Type of Packaging, 2024, 2028 and 2035

17. SUSTAINABLE PACKAGING MARKET, BY TYPE OF PACKAGING CONTAINER

17.1. Chapter Overview

17.2. Key Assumptions and Methodology

17.3. Sustainable Packaging Market for Primary Packaging Containers

17.4. Sustainable Packaging Market for Secondary Packaging Containers

17.5. Sustainable Packaging Market for Tertiary Packaging Containers

18. SUSTAINABLE PACKAGING MARKET, BY END-USERS

18.1. Chapter Overview

18.2. Key Assumptions and Methodology

18.3. Sustainable Packaging Market: Distribution by End-users, 2024, 2028 and 2035

19. SUSTAINABLE PACKAGING MARKET, BY KEY GEOGRAPHICAL REGIONS

19.1. Chapter Overview

19.2. Key Assumptions and Methodology

19.3. Sustainable Packaging Market: Distribution by Key Geographical Regions, 2024, 2028 and 2035

20. CONCLUSION

21. EXECUTIVE INSIGHTS

For more information about this report visit https://www.researchandmarkets.com/r/665x2b

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241001224193/en/